Multiomics Market Size Worth $8,696.36 Million By 2032 | CAGR: 15.3%

The global multi-omics market size is expected to reach USD 8,696.36 Million by 2032, according to a new study by Polaris Market Research. The report “Multiomics Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Products, and Services); By Type (Single-cell Multi-omics, and Bulk Multi-omics); By Platform; By Application; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The multi-omics market is significantly driven by the increasing investment in advanced 3D multi-omics profiling by the pharmaceutical & biotechnology companies due to its various benefits, such as enhanced drug development and comprehensive understanding. For instance, in November 2023, Stellaromics, a provider of multi-omics technology, raised USD 25 million in series A funding to advance 3D spatial multi-omics profiling.

Integration of Artificial Intelligence (AI), Machine Learning (ML), and the Internet of Things (IoT) in multi-omics creates significant opportunities for the market. This technology improves data integration, automation, and decision-making processes. AI and ML technologies analyze large volumes of complex data with the help of omics technologies and make accurate predictions with the help of charts and patterns. For instance, in March 2024, NVIDIA introduced NVIDIA Parabricks v4.3 integrated with AI techniques for multiple omics data types. NVIDIA Parabricks v4.3 analyzes multiple omics data types, including DNA, RNA, methylation, single-cell, and spatial omics workloads, using generative AI. Such integration of AI in the multi-omics field is expected to drive the market revenue during the forecast period.

Furthermore, the increasing adoption of cloud-based software transforms multi-omics data insights into advanced scientific discoveries. The market players such as Google, SCIEX OS, and PerkinElmer are considerably contributing to the market growth funding and new cloud-based product launches, to stay competitive in the market. For instance, in June 2023, Form Bio and Google Cloud partnered to provide multi-omics and precision medicine through the “Google Cloud Multi-omics Suite.” Similarly, in May 2023, Google Cloud launched an AI-powered multi-omics suite for the interpretation of genomic data.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/multiomics-market/request-for-sample

Single-cell omics technologies are widely used in cancer research. This technology can detect early-stage tumours, rare cancer cell populations, and circulating tumour cells in blood samples. Therefore, market players are consistently forming partnerships and launching new products to meet the demand for this technology. For instance, in June 2023, Honeycomb Biotechnologies & Revvity launched a new solution, HIVE CLX, for single-cell research. The HIVE CLX solution is designed to enable clinical researchers to overcome challenges in single-cell studies.

Multi-omics Market Report Highlights

• Single-cell multi-omics segment accounted for the largest market share in 2023, owing to its use in developmental biology, & cancer biology for early disease diagnosis.
• The metabolomics segment is expected to witness the highest growth during the forecast period, owing to technological advancement in metabolomics platforms.
• Asia Pacific is projected to register the fastest growth over the study period, attributable to growing investments in cancer research enabling the use of multi-omics tools.
• The global players include BD, Thermo Fisher Scientific, Illumina, Inc., Danaher (Beckman Coulter), Perkin Elmer, Shimadzu Corporation, and Bruker

Polaris Market Research has segmented the multi-omics market report based on product & service, type, platform, application, and region:

Multiomics, Product & Service Outlook (Revenue - USD million, 2019 - 2032)

• Products
  • Instruments
  •  Consumables
  •  Software
• Services

Multiomics, Type Outlook (Revenue - USD million, 2019 - 2032)

• Single-cell Multi-omics
• Bulk Multi-omics

Multiomics, Platform Outlook (Revenue - USD million, 2019 - 2032)

• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Integrated Omics Platforms

Multiomics, Application Outlook (Revenue - USD million, 2019 - 2032)

• Cell Biology
• Oncology
• Neurology
• Immunology

Multiomics, Regional Outlook (Revenue - USD million, 2019 - 2032)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Multiomics Market Report Scope